Gallacher Capital Management »

Takeda Pharmaceutical shares owned by Gallacher Capital Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Gallacher Capital Management from 13F filings

Historical chart of Gallacher Capital Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Gallacher Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Gallacher Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $245k 17k 14.22
2024-06-30 $225k 17k 12.94
2024-03-31 $225k 16k 13.89
2023-12-31 $218k 15k 14.27
2023-09-30 $239k 16k 15.47
2023-06-30 $239k 15k 15.71
2023-03-31 $231k 14k 16.48
2022-12-31 $173k 11k 15.60

More positions owned by Gallacher Capital Management

Pepsi (PEP)
Cassava Sciences Call Option (SAVA)
Alps Etf Tr Smith Core Plus (SMTH)
Yum! Brands (YUM)
Ishares Tr S&p 500 Grwt Etf (IVW)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Apple (AAPL)
Ishares Msci Emrg Chn (EMXC)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
J P Morgan Exchange Traded F Income Etf (JPIE)

View all positions for Gallacher Capital Management

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Renaissance Technologies
First Trust Advisors
Brandes Investment Partners
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management
BlackRock

View all funds holding Takeda Pharmaceutical